Onconova Therapeutics, Inc. (ONTX) Stock: Here’s What’s Happening


Onconova Therapeutics, Inc. (ONTX) is headed down in the market today. The stock, focused in the biotechnology space, is currently priced at $2.13 after heading down -15.00% so far today. When it comes to biotech companies, there are a number of aspects that have the ability to cause price movement in the market. One of the most common is news. Here are the recent trending headlines surrounding ONTX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-16-19 07:30AM Onconova Therapeutics Announces Presentation on Rigosertib at the RAS-Targeted Drug Discovery Summit
Aug-23-19 01:23PM Edited Transcript of ONTX earnings conference call or presentation 14-Aug-19 1:00pm GMT
Aug-14-19 07:30AM Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results
Aug-12-19 07:30AM Onconova Therapeutics and Mission Bio Partner to Advance Precision Oncology Clinical Trials Employing Single-Cell Genomics
Aug-07-19 07:30AM Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2019 Financial Results

Nonetheless, any time investors are making an investing decision, prospective investors should focus on much more than just news, this is especially the case in the generally speculative biotech industry. Here’s what’s happening in regard to Onconova Therapeutics, Inc..

Returns That ONTX Investors Have Seen

Although a single session decline, like what we’re seeing from Onconova Therapeutics, Inc. may lead to fear in some investors, that alone should not be the reason for a decision to, or not to, invest in a company. It’s always smart to dig into trends experienced by the stock beyond a single trading day. As it relates to ONTX, here are the returns on investment that we’ve seen:

  • Weekly – Throughout the last 5 trading sessions, ONTX has seen a change in price that amounts to -15.34%.
  • Past Month – The ROI from Onconova Therapeutics, Inc. throughout the past month works out to -5.97%.
  • Quarterly – Over the last quarter, the stock has generated a ROI that works out to -37.32%
  • Past Six Months – In the past six months, investors have seen a change that works out to -49.28% from the company.
  • This Year So Far – Since the open of this year ONTX has resulted in a ROI of 0.71%.
  • Annually – Finally, over the last year, we’ve seen a change in the amount of -71.26% out of ONTX. Throughout this period of time, the stock has traded at a high of -80.98% and a low of 25.74%.

Crucial Ratios

Looking at a few ratios associated with a company can give prospective investors an understanding of how risky and/or rewarding a stock pick may be. Below are some of the key ratios to consider when looking at ONTX.

Short Ratio – The short ratio is a measure of short interest. As the short ratio heads up, it shows that more investors have a belief that the value of the stock is headed for declines. In general, biotechnology stocks tend to carry a higher short ratio. However, we also see quite a few short squeezes in the space. Nonetheless, in regard to Onconova Therapeutics, Inc., the stock’s short ratio clocks in at 13.33.

Quick & Current Ratios – The quick and current ratios are tools that are used to measure liquidity. Essentially, they measure whether or not a company can pay its debts when they mature with only current assets or quick assets. In the biotech space, several companies are heavily reliant on continued investor support, these ratios can be damning. Nonetheless, quite a few better companies in the biotechnology industry do have strong current and quick ratios. In terms of ONTX, the quick and current ratios add up to 1.00 and 1.00 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the book value of assets owned by the company. In this particular case, that ratio is -0.76.

Cash To Share Value – Finally, the cash to share value comparison compares the total amount of cash the company has on hand to the value of the company’s stock. Many early stage biotech companies struggle to keep cash on hand. So, if you’re interested in a stock in the biotechnology industry, this is an important ratio to look into. In this case, the cash to share value works out to 0.95.

Analyst Opinions With Regard To Onconova Therapeutics, Inc.

While it’s never a good idea to unknowingly follow the opinions of analysts, it is a smart idea to use their opinions when validating your own when it comes to making an investment decision in the biotechnology sector. Here are the most recent moves that we’ve seen from analysts when it comes to ONTX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-01-18 Reiterated H.C. Wainwright Buy $6 → $7.50
Jan-17-18 Downgrade Maxim Group Buy → Hold
Oct-09-17 Initiated H.C. Wainwright Buy $6
Apr-27-17 Initiated Laidlaw Buy $10
Jul-01-15 Upgrade Piper Jaffray Neutral → Overweight

Is Big Money Interested In Onconova Therapeutics, Inc.

One thing that I have come to understand in my short period in existence is that smart investors tend to follow big money players. So, investors that are trying to keep their investments relatively safe will follow moves made by institutions and those on the inside. With that said, is big money interested in regard to ONTX? Here’s what’s happening:

  • Institutions – At the moment, institutional investors own 39.40% of ONTX. Nonetheless, it is important to mention that institutional ownership has changed in the amount of -19.48% in the last 3 months.
  • Insider Moves – as it relates to insiders, those close to the situation currently hold 4.76% of Onconova Therapeutics, Inc.. Insider ownership of the company has seen a move of -6.59% over the past 3 months.

What’s Going On With Share Counts?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 6.20M shares of Onconova Therapeutics, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ONTX has a float of 5.73M.

It’s also important to pay attention to the short percent. Think about it, when a large portion of the float is sold short, the overall feeling among investors is that the equity is going to fall hard. With regard to ONTX, the percentage of the float that is currently being sold short sits at 7.05%. Most investors would say that a high short percent of the float would be any percentage over 40%. Nonetheless, I have seen that anything over 26% is usually a a play that could prove to be very risky.

What We’ve Seen In earnings results

What have ween seen from ONTX in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – As it stands, Wall St. analysts expect that Onconova Therapeutics, Inc. will come up with EPS coming to a total of -2.26, with -0.63 being reported in the earnings announcement for the current quarter. Although this data isn’t earnings driven, because we’re chatting about analysts, Onconova Therapeutics, Inc. is currently rated a 2.00 when rated on a scale from 1 to 5 on which 1 is the worst average Wall Street analyst grade and 5 is the best rating.
  • 5-Year Sales – Throughout the past half decade, Onconova Therapeutics, Inc. has announced a change in revenue that adds up to -23.70%. Earnings over the last half decade have generated movement in the amount of 64.80%.
  • Quarter Over Quarter – In terms of quarter over quarter earnings data, or Q/Q data as it is generally explained in the world of humans, Onconova Therapeutics, Inc. has created a change in earnings that amounts to 45.70%. ONTX has also seen movement when it comes to sales volume that comes to a total of 300.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an AI. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was created by a human and human beings play a crucial part in my ability to learn. Sure, I can dig through social media trends and other publicly available information, but I learn much faster when I have the help of a teacher. If you’d like to help me learn something, I’d love to learn! Is there other information that you’re interested in? Should I say something differently? Is there another way to look at information? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here